EnteroMedics will modify its obesity-treating neuromodulation system for Galvani Bioelectronics to use in preclinical research.
Verily designed the lab to Freenome’s specifications to foster collaboration after quietly participating in its $65 million financing round in March.
Takeda and BioSurfaces are teaming up to create devices for the treatment of gastrointestinal disease based on the latter's nanofiber technology.
Celgene has announced a new arm of a phase 1b study that will study Novocure’s noninvasive brain cancer therapy alongside a pair of cancer drugs.
IBM and the University of Alberta developed algorithms that predict schizophrenia, which could lead to objective measures to diagnose the disorder.
The series B round equips Amphora to take its minimally invasive, cystoscopic device into the last step of clinical development next year.
Mayo Clinic and AliveCor are developing a low-cost, portable screening tool for long QT, which can cause sudden cardiac death.
Simplify Medical raised $21 million in series B funding to support two U.S. pivotal trials of its nonmetal cervical artificial disc.
Quest Diagnostics has completed its acquisition of a pair of laboratory businesses in Texas, establishing a foothold in the southwestern U.S.
The finding suggests doctors could use biomarkers tied to the visual system to spot the disease early and monitor its advance.